Furthermore, the knockout of EGFR (or IGF-IR) abolished the E2-proliferative response in mice, and the inhibition of EGFR activity suppressed the proliferative effect of E2 in breast cancer cells in vitro [79, 89]. Here, EGFR is linked to breast cancer.